CA Patent

CA3051977A1 — Pharmaceutical compositions for combination therapy

Assigned to Genfit SA · Expires 2018-08-30 · 8y expired

What this patent protects

The present invention relates to a combination of active ingredients for use in the treatment of diseases.

USPTO Abstract

The present invention relates to a combination of active ingredients for use in the treatment of diseases.

Drugs covered by this patent

maralixibat-chloride (MARALIXIBAT CHLORIDE)

Patent Metadata

Patent number: CA3051977A1
Jurisdiction: CA
Classification: —
Expires: 2018-08-30
Drug substance claim: No
Drug product claim: No
Assignee: Genfit SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.